ArticleJournal of virology2024

A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease.

Sham Nambulli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.